Global Necrotizing Enterocolitis Treatment Market - Industry Trends and Forecast to 2028

Market Analysis and Insights: Global Necrotizing Enterocolitis Treatment Market

Necrotizing enterocolitis treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 5.10% in the above-mentioned research forecast period. Increase in prevalence of necrotizing enterocolitis and increasing child birth.

Easy availability of antibiotic drugs and improving regulatory framework also boost up the market growth. Moreover, increase research and development activities and increasing government support along with increasing contribution of marketers including FDA orphan drug designation act as opportunity for the market growth. But, lack of skilled or trained professionals to carry out efficient diagnosis, side effects associated drugs, poor healthcare system in low and middle income countries may hamper the global necrotizing enterocolitis treatment market.

Necrotizing enterocolitis is intestinal inflammation usually inflammation of colon which proved to be life-threatening if not treated appropriately. Necrotizing enterocolitis affects only the intestinal lining which results in formation of hole in intestinal wall. The hole formed in intestinal wall causes the leakage of usual bacteria present in intestine to abdomen and hence causes infection to other nearby body organs. The infection caused progress at a rapid rate and takes a form of medical emergency. NEC most commonly reported to affect new born babies within 3-12 days after birth. The various symptoms associated with NEC include poor tolerance to feelings, bloody stool, redness to tummy, lethargy, fever, apnea among others. The most common treatment approach used for NEC includes antibiotics, vasopressors, glucocorticoids, opioid analgesics among others.

As per the publication of NCBI, NEC is the leading cause of death due to gastrointestinal infection among infants with reported cases of 1-3 per 1000 births per year in North America. This increasing patient population have several symptoms which demands effective treatment hence expected to provide market with the lucrative growth.

This necrotizing enterocolitis treatment market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Necrotizing Enterocolitis Treatment Market Scope and Market Size

Necrotizing enterocolitis treatment market is segmented on the basis of treatment, route of administration, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of treatment, the necrotizing enterocolitis treatment market is segmented into antibiotics, vasopressors, glucocorticoids, opioid analgesics. Antibiotics segment is further sub-segment into cefotaxmine, ampicillin, gentamicin, vancomycin, clindamycin, metronidazole among others. Vasopressors segment is further sub-segment into dopamine, dobutamine, naloxone, epinephrine. Glucorticosteroids is sub-segmented into hydrocortisone and others. Opioid analgesics is sub-segmented into morphine sulphate, fentanyl and others.
• On the basis of route of administration, the necrotizing enterocolitis treatment market is segmented into oral, parenteral, others.
• On the basis of end-users, the necrotizing enterocolitis treatment market is segmented into pediatric clinics, hospitals, homecare, others.
• On the basis of distribution channel, the necrotizing enterocolitis treatment market has also been segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy, others. 

Necrotizing Enterocolitis Treatment Market Country Level Analysis

Necrotizing enterocolitis treatment market is analysed and market size information is provided by country, treatment, route of administration, end-users and distribution channel as referenced above.

The countries covered in the necrotizing enterocolitis treatment market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America accounts the largest market share due to increasing prevalence of necrotizing enterocolitis and well- developed technologies for disease diagnosis. Moreover increasing healthcare expenditure is acting as another factor driving the North America market. Europe accounts the second largest market share due to increasing contribution towards the research and development activities and growing awareness. Asia-Pacific is expected to account for the largest market share over coming years for the necrotizing enterocolitis treatment market due to presence of huge patient pool and increasing demand of effective treatment.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Necrotizing enterocolitis treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Necrotizing Enterocolitis Treatment Market Share Analysis

Necrotizing enterocolitis treatment market competitive landscape provides details by competitor, details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to necrotizing enterocolitis treatment market.

The major players covered in the necrotizing enterocolitis treatment market are Sandoz AG, Lupin Ltd, Aurobindo Pharma, Kyongbo pharmaceutical Co.,Ltd., Pfizer Inc., Uquifa,  Zydus Cadila, Xinyu Pharmaceutical Co., Ltd., Aurobindo Pharma USA., RECORDATI S.p.A., Mylan N.V., Bristol-Myers Squibb Company, Infant Bacterial Therapeutics, Leadiant Biosciences, Inc., Leadiant Biosciences, Inc., Enzon Pharmaceuticals, Inc., GlaxoSmithKline plc., F. Hoffmann-La Roche Ltd, Plakous Therapeutics, Inc., Prometic Life Sciences Inc.  among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-60216